Mitochondrial Pathobiology and Metabolic Remodeling in Progression to Overt Systolic Heart Failure.
Antoine H ChaanineThierry H LeJemtelPatrice DelafontainePublished in: Journal of clinical medicine (2020)
The mitochondria are mostly abundant in the heart, a beating organ of high- energy demands. Their function extends beyond being a power plant of the cell including redox balance, ion homeostasis and metabolism. They are dynamic organelles that are tethered to neighboring structures, especially the endoplasmic reticulum. Together, they constitute a functional unit implicated in complex physiological and pathophysiological processes. Their topology in the cell, the cardiac myocyte in particular, places them at the hub of signaling and calcium homeostasis, making them master regulators of cell survival or cell death. Perturbations in mitochondrial function play a central role in the pathophysiology of myocardial remodeling and progression of heart failure. In this minireview, we summarize important pathophysiological mechanisms, pertaining to mitochondrial morphology, dynamics and function, which take place in compensated hypertrophy and in progression to overt systolic heart failure. Published work in the last few years has expanded our understanding of these important mechanisms; a key prerequisite to identifying therapeutic strategies targeting mitochondrial dysfunction in heart failure.
Keyphrases
- heart failure
- left ventricular
- cell death
- endoplasmic reticulum
- cardiac resynchronization therapy
- single cell
- acute heart failure
- atrial fibrillation
- blood pressure
- cell therapy
- high resolution
- randomized controlled trial
- systematic review
- transcription factor
- stem cells
- mass spectrometry
- cancer therapy
- network analysis